House dust mite allergen activates human eosinophils via formyl peptide receptor and formyl peptide receptor-like 1

European Journal of Immunology

Volumn 37, Issue 7, 2007, Pages 1966-1977

  Svensson, Lena ^a,e   Redvall, Elin ^a   Björn, Camilla ^a   Karlsson, Jennie ^b   Bergin, Ann Marie ^a,f   Rabiet, Marie Josèphe ^c   Dahlgren, Claes ^b   Wennerås, Christine ^a,d  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c CEA GRENOBLE   (France)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^f QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Allergy; Cell activation; Eosinophils; Human

Indexed keywords

CALCIUM ION; CHEMOKINE RECEPTOR CCR3; FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR LIKE 1; G PROTEIN COUPLED RECEPTOR; HOUSE DUST ALLERGEN; LEUKOTRIENE RECEPTOR; LEUKOTRIENE RECEPTOR B4; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PERTUSSIS TOXIN; POLLEN ANTIGEN; PROTEIN KINASE C INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BIRCH; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CHEMOTAXIS; CLONAL ANERGY; CONTROLLED STUDY; DEGRANULATION; EOSINOPHIL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; NEUTROPHIL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, DERMATOPHAGOIDES; BETULA; CALCIUM; CHEMOTAXIS, LEUKOCYTE; EOSINOPHILS; HL-60 CELLS; HUMANS; POLLEN; POLYMERASE CHAIN REACTION; RECEPTORS, CHEMOKINE; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LEUKOTRIENE B4; RECEPTORS, LIPOXIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 34447550365     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636936     Document Type: Article

References (28)

1. Svensson, L., Rudin, A. and Wennerås, C., Allergen extracts directly mobilize and activate human eosinophils. Eur. J. Immunol. 2004. 34: 1744-1751.
2. Plotz, S. G., Traidl-Hoffmann, C., Feussner, I., Kasche, A., Feser, A., Ring, J., Jakob, T. and Behrendt, H., Chemotaxis and activation of human peripheral blood eosinophils induced by pollen-associated lipid mediators. J. Allergy Clin. Immunol. 2004. 113: 1152-1160.
3. Sohn, M. H., Lee, Y. A., Jeong, K. Y., Sim, S., Kim, K. E., Yong, T. S. and Shin, M. H., German cockroach extract induces activation of human eosinophils to release cytotoxic inflammatory mediators. Int. Arch. Allergy Immunol. 2004. 134: 141-149.
4. Traidl-Hoffmann, C., Kasche, A., Jakob, T., Huger, M., Plotz, S., Feussner, I., Ring, J. and Behrendt, H., Lipid mediators from pollen act as chemoattractants and activators of polymorphonuclear granulocytes. J. Allergy Clin. Immunol. 2002. 109: 831-838.
5. Svensson, L., Dahlgren, C. and Wennerås, C., The chemoattractant Trp-Lys-Tyr-Met-Val-d-Met activates eosinophils through the formyl peptide receptor and one of its homologues, formyl peptide receptor-like 1. J. Leukoc. Biol. 2002. 72: 810-818.
6. Svensson, L. and Wennerås, C., Human eosinophils selectively recognize and become activated by bacteria belonging to different taxonomic groups. Microbes infect. 2005. 7: 720-728.
7. Stenfeldt, A.-L. and Wennerås, C., Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils. Immunology 2004. 112: 605-614.
8. Durstin, M., Gao, J. L., Tiffany, H. L., McDermott, D. and Murphy, P. M., Differential expression of members of the N-formylpeptide receptor gene cluster in human phagocytes. Biochem. Biophys. Res. Commun. 1994. 201: 174-179.
9. Seifert, R. and Wenzel-Seifert, K., The human formyl peptide receptor as model system for constitutively active G-protein-coupled receptors. Life Sci. 2003. 73: 2263-2280.
10. de Paulis, A., Ciccarelli, A., de Crescenzo, G., Cirillo, R., Patella, V. and Marone, G., Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine. J. Allergy Clin. Immunol. 1996. 98: 152-164.
11. Ali, H., Richardson, R. M., Haribabu, B. and Snyderman, R., Chemoattractant receptor cross-desensitization. J. Biol. Chem. 1999. 274: 6027-6030.
12. Yang, D., Chen, Q., Gertz, B., He, R., Phulsuksombati, M., Ye, R. D. and Oppenheim, J. J., Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation. J. Leukoc. Biol. 2002. 72: 598-607.
13. Rodriguez-Frade, J. M., Mellado, M. and Martinez, A. C., Chemokine receptor dimerization: Two are better than one. Trends Immunol. 2001. 22: 612-617.
14. Heit, B., Tavener, S., Raharjo, E. and Kubes, P., An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients. J. Cell. Biol. 2002. 159: 91-102.
15. Boehme, S. A., Sullivan, S. K., Crowe, P. D., Santos, M., Conlon, P. J., Sriramarao, P. and Bacon, K. B., Activation of mitogen-activated protein kinase regulates eotaxin-induced eosinophil migration. J. Immunol. 1999. 163: 1611-1618.
16. Kampen, G. T., Stafford, S., Adachi, T., Jinquan, T., Quan, S., Grant, J. A., Skov, P. S. et al., Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Blood 2000. 95: 1911-1917.
17. Holub, A., Byrnes, J., Anderson, S., Dzaidzio, L., Hogg, N. and Huttenlocher, A., Ligand density modulates eosinophil signaling and migration. J. Leukoc. Biol. 2003. 73: 657-664.
18. 4 receptor. Blood 2000. 95: 1810-1818.
19. Le, Y., Gong, W., Li, B., Dunlop, N. M., Shen, W., Su, S. B., Ye, R. D. and Wang, J. M., Utilization of two seven-transmembrane, G-protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. J. Immunol. 1999. 163: 6777-6784.
20. Migeotte, I., Riboldi, E., Franssen, J. D., Gregoire, F., Loison, C., Wittamer, V., Detheux, M. et al., identification and characterization of an endogenous chemotactic ligand specific for FPRL2. J. Exp. Med. 2005. 201: 83-93.
21. de Paulis, A., Prevete, N., Fiorentino, I., Walls, A. F., Curto, M., Petraroli, A., Castaldo, V. et al., Basophils infiltrate human gastric mucosa at sites of Helicobacter pylori infection, and exhibit chemotaxis in response to H. pylori-derived peptide Hp(2-20). J. Immunol. 2004. 172: 7734-7743.
22. Denburg, J. A., Telizyn, S., Messner, H., Lim, B., Jamal, N., Ackerman, S. J., Gleich, G. J. and Bienenstock, J., Heterogeneity of human peripheral blood eosinophil-type colonies: Evidence for a common basophil-eosinophil progenitor. Blood 1985. 66: 312-318.
23. Jackson, W. T., Froelich, L. L., Boyd, R. J., Schrementi, J. P., Saussy, D. L., Jr., Schultz, R. M., Sawyer, J. S. et al., Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: In vitro studies. J. Pharmacol. Exp. Ther. 1999. 288: 286-294.
24. Goldman, D. W. and Goetzl, E. J., Heterogeneity of human polymorphonuclear leukocyte receptors for leukotriene B4. Identification of a subset of high affinity receptors that transduce the chemotactic response. J. Exp. Med. 1984. 159: 1027-1041.
25. Marinissen, M. J. and Gutkind, J. S., G-protein-coupled receptors and signaling networks: Emerging paradigms. Trends Pharmacol. Sci. 2001. 22: 368-376.
26. Bae, Y. S., Lee, H. Y., Jo, E. J., Kim, J. I., Kang, H. K., Ye, R. D., Kwak, J. Y. and Ryu, S. H., Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. J. Immunol. 2004. 173: 607-614.
27. Karlsson, J., Fu, H., Boulay, F., Bylund, J. and Dahlgren, C., The peptide Trp-Lys-Tyr-Met-Val-d-Met activates neutrophils through the formyl peptide receptor only when signaling through the formylpeptide receptor like 1 is blocked. A receptor switch with implications for signal transduction studies with inhibitors and receptor antagonists. Biochem. Pharmacol. 2006. 71: 1488-1496.
28. Partida-Sanchez, S., Cockayne, D. A., Monard, S., Jacobson, E. L., Oppenheimer, N., Garvy, B., Kusser, K. et al., Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo. Nat. Med. 2001. 7: 1209-1216.